Study of Glucose Tolerance Abnormalities Using Continuous Glucose Monitoring for the Identification of Early Loss of Pancreatic Islet Graft Function.

NCT07470593 · clinicaltrials.gov ↗

RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes (T1D)

Interventions

OTHER: Continuous glucose monitoring (CGM) with TITR measurement

Sponsor

University Hospital, Strasbourg, France